Cost containment and M&A shape the global generics industry

This report analyses both quantitatively and qualitatively the unbranded generics industry, the Top 10 generics companies by unbranded generics sales, the Top five therapy areas and the major North American, European, Asia Pacific and Latin American markets.

Generics Overview in the Seven Major Markets

Increasing generics volume uptake will provide much needed cost-savings in the less mature markets of France, Italy, Spain, and Japan, and requires regulators to incorporate effective utilization incentives for key stakeholders. While volume will grow in the US, Germany, and the UK, regulators are increasingly looking to capture value from generics by pushing down price and speeding market access.

Europe Picture Archiving and Communication Systems (PACS) Market: Market Analysis and Opportunity Assessment

GlobalData's "Europe Picture Archiving and Communication Systems (PACS) Market: Market Analysis and Opportunity Assessment" report is an essential source of data and analysis on the Europe PACS market. The report provides market landscape, competitive landscape and market trends information on the Europe PACS market. The report identifies the key trends shaping and driving the dynamism in the Europe PACS market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also provides valuable insight on the pipeline products within the Europe PACS market.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

US Surgical Sutures Market: Surgical Procedures Growth to Drive Demand

GlobalData's "US Surgical Sutures Market: Surgical Procedures Growth to Drive Demand" report is an essential source of data and analysis on the US surgical sutures market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on two market categories - absorbable sutures and non absorbable sutures. The report identifies the key trends shaping and driving the dynamism in the US surgical sutures market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also provides valuable insight on the pipeline products within the US surgical sutures market.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report! 

The Evolving Pharma M&A Landscape: Emerging trends and predicted post-blockbuster targets

The report identifies the factors responsible for growing pressure on leading pharmaceutical businesses and strategic responses being pursued by the industry. It includes a critical appraisal of mega-mergers triggered by similar factors in the past, and an analysis of the two mega-mergers that have been announced since the beginning of 2009.

Colorectal Cancer - Growing trend towards personalized medicine

CRC incidence will be over 490,000 cases by 2018 in the seven major markets. This large patient base will translate into a high commercial potential for the development of novel, more effective therapies. Currently, there are 77 agents in development for CRC, 4 of which are in late-phase development. Collectively, they are forecast to achieve sales of $1,398m by 2018.

New Multi-Marketing Channel Strategies

The future of Pharma marketing lies in using new marketing channels such as social media intertwined with traditional marketing practices to create a multi-channel marketing mix. However, online brand promotion through social media is more effective for targeting patients than physicians, indicating direct marketing tactics to physicians through social media should be limited.

Generic Strategies in Emerging Markets

The emerging markets are luring a growing number of pharma companies looking to compensate for the diminishing revenues in developed markets. Latin America and Central and Eastern Europe (CEE) are showing strong growth rates, proving to be lucrative targets for firms aiming to expand their foothold, initially as a generics player, but also providing a foundation for subsequent brand penetration.